Sitemap
June 04, 2023 Articles
Filter by Available Specialty
- ASPC announces program for annual Congress on CVD Prevention
- Despite evidence of durability, belantamab mafodotin misses endpoint for multiple myeloma
- Healio | HemOncToday announce 2023 Disruptive Innovators at ASCO
- Late-toxicity burden high among survivors of high-risk neuroblastoma
- Long-duration trastuzumab remains standard of care in HER2-positive breast cancer
- NCI director: ‘Committed and collective action’ required to achieve Moonshot goal
- Neoadjuvant chemotherapy regimen shows durable survival benefit in rectal cancer
- Nivolumab regimen ‘a huge advance’ in treatment of classical Hodgkin lymphoma
- Osimertinib after surgery reduces risk for death by 51% in resected EGFR-mutant NSCLC
- Some patients with locally advanced rectal cancer can be spared pelvic radiation
- Talazoparib extends PFS in maintenance regimen for small cell lung cancer subgroup
- Toripalimab regimen delays progression of PD-L1-positive triple-negative breast cancer
- VIDEO: ECP a versatile MIGS option with or without cataract surgery
- Vorasidenib first ‘game changer’ in 20 years for patients with IDH-mutant grade 2 glioma
- Waypoint Orthopedics receives FDA 510(k) clearance of smart bone awl for pedicle screws